FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / News / Read News


GTCR Promotes Kos to Managing Director

August 23, 2021, 08:00 AM
Filed Under: Private Equity

GTCR, a leading private equity firm, announced the promotion of John D. Kos to Managing Director.
Mr. Kos initially joined GTCR in 2006. He was promoted to Vice President in 2011 and Principal in 2017. Among his many contributions to the firm and its limited partners, Mr. Kos has led GTCR's growth initiatives at several instrumental healthcare investments, including Antylia Scientific, Cedar Gate Technologies and Transaction Data Systems, and he also works closely with Water's Edge/Riverchase Dermatology. He was involved in several past GTCR investments including CCS, Cole-Parmer Instrument Company, GreatCall and XIFIN.

Prior to joining GTCR, Mr. Kos worked as an Analyst in the healthcare investment banking group of Citigroup Global Markets in New York. He holds an MBA with distinction from Harvard Business School and a BS in finance from the University of Illinois.

"On behalf of my partners at GTCR, we would like to congratulate John on his new leadership role at the firm," said Dean Mihas, GTCR Managing Director and Co-CEO. "He is an exceptional investment professional with tremendous healthcare insights. He has spearheaded the firm's efforts in the healthcare IT industry, where GTCR has made several investments. He is an excellent addition to our experienced senior management team."

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.